Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?